Note 19 - Subsequent Events |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 | |||
Notes to Financial Statements | |||
Subsequent Events [Text Block] |
The Company has evaluated subsequent events through the date which the consolidated financial statements were available to be issued.
The Company held a warrant (“Series A Warrant”) to purchase an additional 500 shares of LINICO Series A Preferred Stock at an exercise price of $1,000 per share. Subsequent to year end, the Company exercised the warrant for all 500 LINICO Series A Preferred shares. Following the exercise, the Company held a total of 2,000 shares of the Series A Preferred Stock representing approximately 12% of LINICO common stock on a fully diluted basis.
Subsequent to the year end, the Alameda lease was terminated.
|